443 related articles for article (PubMed ID: 19549172)
1. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants.
Wikraiphat C; Charoensap J; Utaisincharoen P; Wongratanacheewin S; Taweechaisupapong S; Woods DE; Bolscher JG; Sirisinha S
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):253-9. PubMed ID: 19549172
[TBL] [Abstract][Full Text] [Related]
2. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation.
Taweechaisupapong S; Kaewpa C; Arunyanart C; Kanla P; Homchampa P; Sirisinha S; Proungvitaya T; Wongratanacheewin S
Microb Pathog; 2005 Sep; 39(3):77-85. PubMed ID: 16084684
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
DeShazer D; Waag DM; Fritz DL; Woods DE
Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
[TBL] [Abstract][Full Text] [Related]
4. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence.
Manterola L; Guzmán-Verri C; Chaves-Olarte E; Barquero-Calvo E; de Miguel MJ; Moriyón I; Grilló MJ; López-Goñi I; Moreno E
Infect Immun; 2007 Oct; 75(10):4867-74. PubMed ID: 17664262
[TBL] [Abstract][Full Text] [Related]
5. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.
Cuccui J; Easton A; Chu KK; Bancroft GJ; Oyston PC; Titball RW; Wren BW
Infect Immun; 2007 Mar; 75(3):1186-95. PubMed ID: 17189432
[TBL] [Abstract][Full Text] [Related]
6. [Properties of the Burkholderia pseudomallei insertional mutants deficient in membrane proteins production].
Viktorov DV; Merinova LK; Alekseev VV; Pivnen' NN; Merinova OA; Seimova IK; Timoshin VB; Zakharova IB
Mol Gen Mikrobiol Virusol; 2005; (4):17-20. PubMed ID: 16334220
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.
Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202
[TBL] [Abstract][Full Text] [Related]
8. The mviN homolog in Burkholderia pseudomallei is essential for viability and virulence.
Ling JM; Moore RA; Surette MG; Woods DE
Can J Microbiol; 2006 Sep; 52(9):831-42. PubMed ID: 17110975
[TBL] [Abstract][Full Text] [Related]
9. A role of Burkholderia pseudomallei flagella as a virulent factor.
Chuaygud T; Tungpradabkul S; Sirisinha S; Chua KL; Utaisincharoen P
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S140-4. PubMed ID: 19121676
[TBL] [Abstract][Full Text] [Related]
10. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin.
Chen YS; Hsiao YS; Lin HH; Yen CM; Chen SC; Chen YL
Vaccine; 2006 Feb; 24(6):750-8. PubMed ID: 16169637
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase C is required for intracellular survival and virulence of Burkholderia pseudomallei.
Vanaporn M; Wand M; Michell SL; Sarkar-Tyson M; Ireland P; Goldman S; Kewcharoenwong C; Rinchai D; Lertmemongkolchai G; Titball RW
Microbiology (Reading); 2011 Aug; 157(Pt 8):2392-2400. PubMed ID: 21659326
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2).
Barnes JL; Williams NL; Ketheesan N
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191
[TBL] [Abstract][Full Text] [Related]
14. Polysaccharides and virulence of Burkholderia pseudomallei.
Sarkar-Tyson M; Thwaite JE; Harding SV; Smither SJ; Oyston PCF; Atkins TP; Titball RW
J Med Microbiol; 2007 Aug; 56(Pt 8):1005-1010. PubMed ID: 17644705
[TBL] [Abstract][Full Text] [Related]
15. Flagella are virulence determinants of Burkholderia pseudomallei.
Chua KL; Chan YY; Gan YH
Infect Immun; 2003 Apr; 71(4):1622-9. PubMed ID: 12654773
[TBL] [Abstract][Full Text] [Related]
16. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
17. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
Leakey AK; Ulett GC; Hirst RG
Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859
[TBL] [Abstract][Full Text] [Related]
18. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
[TBL] [Abstract][Full Text] [Related]
19. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
[TBL] [Abstract][Full Text] [Related]
20. The Porphyromonas gingivalis clpB gene is involved in cellular invasion in vitro and virulence in vivo.
Yuan L; Rodrigues PH; Bélanger M; Dunn W; Progulske-Fox A
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):388-98. PubMed ID: 17854400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
